Topics overview

Topics overview

LASA has data available on many different topics in various functional domains. To make it easier for those who would like to make use of LASA data, the topic table below provides an overview of the topics for which data are available in LASA, the corresponding data file number, and the measurement cycles (waves) in which the topic is included. When clicking on the topic name, you will be re-directed to a page with more detailed documentation on the specific topic. This table is a concatenation of all theme tables which can be shown by clicking on the menu-items behind “themes”.

Legend

UC: Under Construction

*: Telephone interview held with respondent or proxy

**: not yet documented

Note I: some of the data are not yet available (in red)

Note II: the table is also horizontally scrollable. So, if e.g. the last column does not show, it can be made visible by sliding the horizontal scroll bar at the bottom of the table forwards. In the desktop version you can also click on an empty space in the table and use the right and left keys on the key board to move the table backwards and forwards

Note III: investigations for the K-wave take place in 2021-2022. Results for this wave will be made available in the course of 2022 or later. Most questionnaire items used in wave K have been available already (see PDF-files “…quest_nl” in the various topics).

 

Topics table

LASA-WAVE BCDE2BFGH3BMBIJK 
Cohort 1
Cohort 2
Cohort 3
Migrant Cohort
THEME BIOMATERIAL
Blood collection and overview
(routine) measurements

Response blood sampling /
DNA Date blood sampling

850


851
850


851
-


-
-


-
850


851
-


-
850


851
-


-
850


851
-


-

-


-
-


-
-


-
Routine measurements
(Albumin and cholesterol)

860860--860-860-860----
Adiponectin, leptin and ghrelin------879------
Apolipoprotein E (ApoE)
- Phenotyping
- Genotyping

870
-

-
-

-
-

-
-

870
-

-
-

-
-

-
-

-
-

-
-

-
-

-
-

-
-
Cholesterol, triglycerides and
fructosamin

-867-----------
COLIA1 (Collagen type I α1 Sp1
polymorphism in LASA)

-871-----------
Cortisol (total plasma cortisol,
corticosteroid binding globuline,
salivary cortisol)
- Serum cortisol
- Salivary cortisol




-
-



864
-



-
-



-
880/
881/
882



-
-



-
-



-
-



-
-



-
-



-
-



-
-



-
-



-
-
Hair cortisol
(LASA ancillary study)

Genetic polymorphisms
(VDR, GR, etc)
- Vit D Receptors
- Haplotypes



-
-


872
873


-
-


-
-


-
-


-
-


-
-


-
-


-
-


-
-


-
-


-
-


-
-
GWAS data
-X--X-X-X----
Exome Chip
-X----X------
Homocysteine, vitamin B12, MMA
-866
-----------
Bone-related hormones and
bone turnover

-862
-----------
Inflammation factors
- Pro-inflammatory cytokine
Interleukin-6 (IL-6)
- Acute-phase proteins C-reactive
protein (CRP)
- A1-antichymotrypsin (ACT)
861861------861----
Serum Amyloid P component (SAP)
-868
-----------
Serum 25-hydroxy-vitamin D
(25(OH)D) and parathyroid
hormone (PTH)

-862
--862-862-862----
Sex hormones
-863
-----------
Thyroid function
-865
-----------
Vitamin K status
----869--------
THEME CARE
Attitudes about care032

112

-
-

-

-
-

-

-
-

-

-
-

112

-
-

112

-
-

112

-
-

112

-
-

112

-
-

112

-
-

112

-
-

112

175
-

112

175
Filial responsibility expectations IM

- scaled
-

-
-

-
132

332
132

332
-

-
-

-
-

-
-

-
-

-
-

-
-

-
132

332
-

-
Vignettes about help

- total scores
-

-
-

-
074

274
-

-
-

-
-

-
-

-
-

-
-

-
-

-
-

-
-

-
-

-
Providing careBCDE2BFGH3BMBIJK
Providing assistance with
personal/household care

----142142142142142142142142142
Family caregiving to older adults
(LASA ancillary study)
X
Use of careBCDE2BFGH3BMBIJK
Use of personal/household care

-tel. proxy*

-tel. respondent*
033

-

-
033

603

703
033

603

703
033

603

703
033

-

-
033

603

703
033

603

703
033

603

703
033

-

-
033

-

-
033

603

703
033

603

703
033

603

703
Care evaluation033033033033033033033033033033033033033
Use of nursing care

-tel. proxy*

-tel. respondent*
-

-

-
-

-

-
-

-

-
-

-

-
-

-

-
-

-

-
-

-

-
033

603

703
033

-

-
033

-

-
033

603

703
033

603

703
033

603

703
Use of transport/admin. care

-tel. proxy*

-tel. respondent*
-

-

-
-

-

-
-

-

-
-

-

-
-

-

-
-

-

-
-

-

-
033

603

703
-

-

-
-

-

-
033

603

703
033

603

703
033

603

703
Personal budget (PGB)-------033-----
Perceived control of care-------033033033033033033
Satisfaction with care033033033033033033033033033033033033033
Need for care-----033033033033033033033033
Aggr. variables care network-------233-----
Use of respite care by R (for partner)----------139139139
Perceived control in health care
and scale
(LASA ancillary study)
       X   
Transitions in care**
(LASA ancillary study)
Adaptations and facilitiesBCDE2BFGH3BMBIJK
Adaptations in the house

(see Theme SOCIAL)
Use of assistive devices or
assistence


(see Theme PHYSICAL)
Contact with servicesBCDE2BFGH3BMBIJK
Contact with health and social
services
044044044044044044044044044044044044044
Hospital admission

-tel. proxy*

-tel. respondent*
045

-

-
045

603

703
045

603

703
045

603

703
045

-

-
045

603

703
045

603

703
045

603

703
045

-

-
045

-

-
045

603

703
045

603

703
045

603

703
Outpatient contact with medical
specialists last 6 months

- specification of specialist
045


245
045


245
045


245
045


245
045


245
045


245
045


245
045


245
045


245
045


245
045


245
045


245
045


245
Health care in country of origin
---------068---
Needs assessmentBCDE2BFGH3BMBIJK
Needs assessment
(WVG/Wmo/AWBZ/Zvw/Wlz)IM


-tel. proxy*

-tel. proxy*

-tel. respondent*

-tel. respondent*
-
-
-

-

-

-

-
-
-
-

-

-

-

-
-
-
-

-

-

-

-
-
-
189

610

-

710

-
-
-
-

-

-

-

-
-
-
189

610

-

710

-
177
178
189

-

611

-

711
177
178
189

-

611

-

711
-
-
-

-

-

-

-
-
-
-

-

-

-

-
177
178
189

-

611

710

711
177
178
189

610

611

710

711
177
178
189

610

611

710

711
Residential care after attrition**            
End of life care and preferencesBCDE2BFGH3BMBIJK
Advance Directives


-tel. respondent*
-
-

-
-
-

709
093
-

709
-
-

-
-
-

-
-
195

-
-
195

-
-
195

-
-
-

-
-
-

-
-
195

-
-
195

-
-
195

-
Feelings and wishes about
life and death
----------127127127
Decisions in eol situations------148------
General eol goals
(see also Subj. life exp.)
------094094094-094094094
Last wishes-----146----- --
Advance Care Planning (ACP)----------108-108
Opinions about euthanasia and
end-of-life (eol) pill
122122122122122122122122122-122122122
End-of-life care:
interviews with proxies
(LASA ancillary study)
   X  X     
THEME COGNITIVE
Intelligence and cognitionBCDE2BFGH3BMBIJK
Crystallized intelligence (GIT ©)

- total scores
-

-
037

237
-

-
-

-
-

-
037

237
-

-
-

-
-

-
-

-
037

237
-

-
-

-
Fluid intelligence (RAVEN)

- scaled

Evaluation RAVEN
022

222


024
022

222


-
022

222


-
022

222


-
022

222


-
022

222


-
022

222


-
-

-

-
-

-

-
-

-

-
-

-

-
-

-

-
-

-

-
Head trauma

- tel. proxy*

- tel. respondent*
-

-

-
-

-

-
035

602

702
035

602

702
-

-

-
035

602

702
035

602

702
035

602

702
-

-

-
-

-

-
035

602

702
035

602

702
035

602

702
Information processing speed
(Coding task)
155155155155155155155155155-155155155
Mini-Mental State Examination
(MMSE)

- MMSE scaled

- MMSE subtraction/spelling

- tel. respondent*
021


221

421


-
021


221

421


707
021


221

421


707
021


221

421


707
021


221

421


-
021


221

421


707

021


221

421


707

021


221

421


707
021


221

421


-
021


221

421


-
021


221

421


707

021


221

421


707
021


221

421

707
Informant Quest. of COgn. DEcline
(IQCODE)
- tel. proxy*
- tel. resp


-


607

607


607

-


607

-


-
-


607

-


607

-


607

-


-
-


-
-


607

-


607

-


607

-
Executive functioningBCDE2BFGH3BMBIJK
Verbal fluency-------165165165165165165
Executive functioning
(Digit span)
-------166020-166166166
MemoryBCDE2BFGH3BMBIJK
Everyday memory023----023-------
Episodic memory (15WT)

- constructed
156

356
156

356
156

356
156

356
156

356
156

356
156

356
156

356
156

356
-

-
156

356
156

356
156

356
Memory complaints

- tel. respondent
021

-
021

707
021

707
021

707
021

-
021

707
021

707
021

707
021

-
021

-
021

707
021

707
021

707
Metamemory

- scaled
124

324
124

324
124

324
-

-
-

-
-

-
-

-
-

-
-

-
-

-
-

-
-

-
-

-
Memory partner---139-139139139139-139139139
DementiaBCDE2BFGH3BMBIJK
Dementia (probable)XXXXXXXX-----
Dementia parents

- tel. respondent*
-

-
-

-
092

702
-

-
092

-
-

-
-

-
-

-
-

-
-

-
-

-
-

-
-

-
Dementia partner---139-139139139139-139139139
 
THEME DEMOGRAPHIC
General
variables
BCDE2BFGH3BMBIJK

(Non-)response*


more detailed
non-response
*

z002

002
z002

002

z002

002
z002

002
z002

002
z002

002
z002

002
z002

002
z002

002
-

002
z002

002

z002

002

z002

002
Age at interview*z008z008z008z008z008z008z008z008z008mb008z008z008z008
Time of
measurement*
z008z008z008z008z008z008z008z008z008mb008z008z008z008
Sex*1z004---z004---z004mb004---
Education1z004---z004---z004mb004---
Nationality*1z004---z004---z004mb004---
Ethnicity*1z004---z004---z004mb004---
Weight factors5   
MortalityBCDE2BFGH3BMBIJK
Mortality dataz990z990z990z990z990z990z990z990z990-z990z990z990
Mortality and
cause of death
- Specified
z991

z992
z991

z992
z991

z992
z991

z992
z991

z992
z991

z992
z991

z992
z991

z992
z991

z992
-

-
z991

z992
z991

z992
z991

z992
GeographyBCDE2BFGH3BMBIJK
Urbanization2z095z095z095z095z095z095z095z095z095mb095z095z095z095
History of
domestic
addresses*
z052z052z052z052z052z052z052z052z052-z052z052z052
  
Living
arrangements
BCDE2BFGH3BMBIJK
Household
composition
*IM
011011011011011011011011011011011011011
Housing
characteristics
IM

see Theme Social
Marital and
partner status
z010
-
-
z010
601
701
z010
601
701
z010
601
701
z010
-
-
z010
601
701
z010
601
701
z010
601
701
z010
-
-
mb010
-
-
z010
601
701
z010
601
701
z010
601
701
  
Religion3BCDE2BFGH3BMBIJK
Church affiliation-z038z038z038z038---z038038---
Church
attendance
--z038z038z038z038z038z038z038038z038038038
  
Socio-economic
status
BCDE2BFGH3BMBIJK
Occupation4016016016016016016016016016016016016016
Income

- Income
specification
017

217
017

-
017

-
017

-
017

-
017

-
017

-
017

-
017

-
017

-
017

-
017

-
017

-
Income decline /
evaluation
019019019019019019019019019019019019019
Health
insurance
*
018------------
  
THEME EMOTIONAL
ADHDBCDE2BFGH3BMBIJK
ADHD
(LASA ancillary study)
- constructed
-

-
-

-
-

-
-

-
-

-
-

-
179

379
-

-
-

-
-

-
-

-
-

-
-

-
  
AnxietyBCDE2BFGH3BMBIJK
Anxiety symptomsIM

- scaled
026

226
026

226
026

226
026

226
-

-
026

226
026

226
026

226
026

226
026

226
026

226
026

226
026

226
Anxiety diagnosesX-XXX-XX--XX
Posttraumatic stress (PTSD)
- scaled
-

-
-

-
091

291
091

291
-

-
-

-
-

-
-

-
-

-
-

-
-

-
-

-
-

-
DepressionBCDE2BFGH3BMBIJK
Depressive
symptoms
- scaled

- tel. proxy*
- tel. respondent*
025

225


-
-
025

225


606
706
025

225


606
706
025

225


606
706
025

225


-
-
025

225


-
706
025

225


-
706
025

225


-
706
025

225


-
-
025

225


-
-
025

225


-
706
025

225


-
706
025

225


-
706
Depression
diagnoses
XXXXXXXXX-XX
Depressive symptoms
and
food-related behaviour
(LASA ancillary study)
 
Mental health problems
and
food-related behaviour
(LASA ancillary study)
 
  
Evaluation of lifeBCDE2BFGH3BMBIJK
Important aspects
of life
110110110110110110110110110-110110110
Satisfaction
with life and
happiness

- 'happiness-line'
110



-
110



-
110



094
110



-
110



-
110



-
110



-
110



-
110



-
-



-
110



-
110



-
110



-
Valuation of life
- scaled
-
-
-
-
-
-
137
337
-
-
137
337
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Generativity-----------802802
  
Personality traitsBCDE2BFGH3BMBIJK
Self-esteem
- scaled
027
-
027
227
027
227
027
227
027
227
027
227
027
227
027
227
027
227
-
-
027
227
027
227
027
227
Mastery
- scaled
027
227
027
227
027
227
027
227
027
227
027
227
027
227
027
227
027
227
027
227
027
227
027
227
027
227
Perceived
self-efficacy
- scaled
028

228
028

228
028

228
028

228
028

228
028

228
028

228
028

228
028

228
-

-
028

228
028

228
028

228
Neuroticism and
social inadequacy
- scaled
123

323
123

323
123

323
123

323
123

323
-

-
-

-
-

-
123

323
-

-
-

-
-

-
-

-
Meta-emotion029--- 143-------
Humor
- scaled
111
311
-
-
111
311
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
General self-
regulation (GSR)
- scaled
-

-
-

-
-

-
-

-
-

-
-

-
149

349
149

349
-

-
-

-
-

-
-

-
-

-
  
(In)dependenceBCDE2BFGH3BMBIJK
Investment in
independence
-----144144144--144144144
Singing and musicBCDE2BFGH3BMBIJK
Singing and making music-------103--103103-
Religiousness1BCDE2BFGH3BMBIJK
Gerotranscendence
(Cosmic
transcendence)
- scaled
-


-
038


238
038


238
038


238
038


238
038


238
-


-
-


-
-


-
-


-
-


-
-


-
-


-
Orthodoxy
- scaled

- scaled
-
-
-
-
038
238

-
-
038
-
-
-
038
-
138
338
038
-
-
-
038
-
-
-
038
-
-
-
038
-
-
-
038
-
-
-
-
-
-
-
038
-
-
-
038
-
-
-
038
-
-
-
Praying-038038038038038038038038-038038038
Salience of
religion
- scaled

- tel. proxy*
- tel. respondent*
110
-
-

-
-
110
038
238


608
708
110
038
238


-
-
110
038
238


-
-
110
038
238


-
-
110
-
-

-
-
110
-
-

-
-
110
-
-

-
-
110
-
-

-
-
-
-
-

-
-
110
-
-

-
-
110
-
-

-
-
110
-
-

-
-
Religious coping--------105105---
SexualityBCDE2BFGH3BMBIJK
Sexuality120--120120120--120----
Gender identity**-----------804804
SleepBCDE2BFGH3BMBIJK
Sleep quality
- scaled
117
317
117
317
117
317
117
317
117
317
117
317
117
317
117
317
117
317
-
-
117
317
117
317
117
317
Stress and
stressors
BCDE2BFGH3BMBIJK
Negative life
eventsIM
-272272272-272272272--272272272
Perceived
stress
- scaled
-

-
-

-
-

-
-

-
-

-
-

-
-

-
104

304
104

304
-

-
-

-
-

-
-

-
Subjective ageBCDE2BFGH3BMBIJK
Subjective life
expectancy/
subj. age
--094094-094094094--094094094
Attitude
toward ageing
071------------
Age norms070070070-070070070070070-070070070
WorryingBCDE2BFGH3BMBIJK
Worrying
- scaled
-
-
-
-
-
-
136
336
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
THEME SOCIAL
AffiliationBCDE2BFGH3BMBIJK
Need for
affiliation


- Scaled
078

-

278
-

-

-
-

-

-
078

-

278
-

141

341
-

-

-
-

141

341
-

-

-
-

-

-
-

-

-
-

-

-
-

-

-
-

-

-
HousingBCDE2BFGH3BMBIJK
Housing
characteristics







Adaptations in
the house
014

015

-

-

014
014

015

601

701

014
014

015

601

701

014
014

015

601

701

014
014

015

-

-

014
014

015

601

701

014
014

015

601

701

014
014

015

601

701

014
014

015

-

-

014
014

015

-

-

-
014

015

601

701

014
014

015

601

701

014
014

015


601

701

014
Relocation



-tel. proxy*

-tel. respondent*
014

015

-

-
014

015

601

701
014

015

601

701
014

015

601

701
014

015

-

-
014

015

601

701
014

015

601

701
014

015

601

701
014

015

-

-
-

-

-

-
014

015

601

701
014

015

601

701
014

015

601

701
Neighborhood
characteristics
015

z095
015

z095
015

z095
015

z095
015

z095
015

z095
015

z095
015

z095
015

z095
-

z095
015

z095
015

z095
015

z095
Pets in
household
**
012012012012012012012012012-012012012
Residence in
1944
**
013------------
Partner relationshipBCDE2BFGH3BMBIJK
Relationship quality---139-139139139139-139139139
Relationships
between
generations
BCDE2BFGH3BMBIJK
Parental data**----140---140----
Children**048

-
048

-
-

-
048

248
048

248
048

248
048

-
-

-
048

248
048

248
048

-
-

-
-

-
Filial
responsibility
expectations IM

- scaled
-



-
-



-
132



332
132



332
-



-
-



-
-



-
-



-
-



-
-



-
-



-
132



332
-



-
Vignettes about
help


-total scores
-


-
-


-
074


274
-


-
-


-
-


-
-


-
-


-
-


-
-


-
-


-
-


-
-


-
Grandchildren**-----049-------
Social networkBCDE2BFGH3BMBIJK
Personal
network

- network size
047


247
047


247
047


247
047


247
047


247
047


247
047


247
047


247

-
047


247
-


-
047


247
047


247
047


247
Contact network--------167167167--
LonelinessBCDE2BFGH3BMBIJK
Loneliness

-scaled

-tel. respondent*

Existential
loneliness
073

273


-

-
073

273


-

-
073

273


-

-
073

273


-

-
073

273


-

-
073

273


-

-
073

273


-

-
073

273


712


-
073

273


-

-
073

273


-

-
073

273


712


-
073

273


712

173
073

273

712


-
Social
participation
BCDE2BFGH3BMBIJK
Social
participation

070

125
070

125
070

125
070

125
070

125
070

125
070

125
070

-
070

-
070

-
070

-
070

-
070

-
Environmental
influence
**
121121121----------
Social normsBCDE2BFGH3BMBIJK
Values and
norms
**
122122122122122122122122122-122122122
Social
desirability**

- scaled
-


-
130


330
-


-
-


-
-


-
130


330
-


-
-


-
-


-
-


-
-


-
-


-
-


-
Social
identity**

- scaled
-


-
-


-
131


331
131


331
-


-
-


-
-


-
-


-
-


-
-


-
-


-
-


-
-


-
 Donorship**
 - - - - - - - - - - 128128-
Ties with
country of origin
**
---------069---
THEME WORK
Work and
Retirement
characteristics
 
Work and
Retirement
– tel. respondent
*
016

-
016

-
016

-
016

-
016

-
016

-
016

-
016

-
016

-
016

-
016

713
016

713
016

713
Physical and
psychosocial
General
Population Job
Exposure Matrix
(GPJEM)

016016016016016016016016016 016016016016
Work Perception

106 106106106106
THEME PHYSICAL
Blood pressureBCDE2BFGH3BMBIJK
Blood pressure/
pulse
- retests
151

-
151

-
151

-
151

-
151

151
151

-
151

151
151

151
151

151
151

-
151

151
151

151
151

151
Body compositionBCDE2BFGH3BMBIJK
Anthropometry

– Weight and height

– Calf measurement

– Ankle, Knee and
Pulse width

161

161

171

161

161



185
161

161

171

161

161

171

161

161

171

161

161

171

161

161

171

161

161

171

161

161

171

161

161




161

161

161

-
161

161

161

-
161

161

161


-
Weight and height
history and
weight change
IM

- tel. respondent*

160



-
160



-
160



-
160



-
160



-
160



-
160



-
160



-
160



-
160



-
160



714

160



714
160



714
Bio-electrical
impedance**
(subsample)

172 --
Birth weight
134134134 --
Perceived body
shape**
– scaled











145

345
145

345



145

345
145

-






DXA
(LASA ancillary study)
– Hip / lumbar spine scan
– Whole body scan





o41
o42


o41
o42






























Chronic diseasesBCDE2BFGH3BMBIJK
Self-report of
chronic diseasesIM

– nr. of diseases
reported

– tel. proxy*

– tel. respondent*

– longitudinally
cleaned

035


235





-

435
035


235



602

702

435
035


235



602

702


-
035


235



602

702


-
035


235



-

-

-
035


235



602

702


-
035


235



602

702


-
035


235



602

702


-
035


235



-

-

-
035


235



-

-

-
035


235



602

702


-
035


235



602

702


-
035


235


602

702

-
GP informationg01g01g01g01UC-g01g01-
Aortic calcification
(lateral radiographs)

zo22zo22-
Diabetes mellitus
(algorithm)

zdc1zdc1zdc1zdc1zdc2zdc1
zdc2
zdc1
zdc2
zdc1
zdc2


zdc3
-zdc1
zdc2
zdc3
UCUC
Rheumatoid
Arthritis
(algorithm)

UC-
Osteoarthritis hip
and knee
(algorithm)

zoa1
zoa1zoa1 zoa1zoa2zoa1
zoa2
zoa1
zoa2
zoa1
zoa2


zoa3
zoa1
zoa2
zoa3
UCUC
Metabolic
syndrome

ch02-
Allostatic Load
(algorithm)

X-
Cardiovascular
diseases
(algorithm)

zh01zh01zh01-
Parkinson: early P.
related signs**

096096-
Decubitus
(bedsores)

116

159
























Hyperthyroidism**
182 182
-
Back pain-182
182
182
-
Bedridden
182182
182
182
182
182
-
FertilityBCDE2BFGH3BMBIJK
Fertility (women)
119 1811 181 181
181
FallingBCDE2BFGH3BMBIJK
Falls

– tel. proxy*

– tel. respondent*

– Falls last year









605

705

187


605

705

187




































187






187












187






187
Falls: circumstances and
consequences

187
187187
Falls: environmental
conditions (home)**

180
180
-
Falls: fear of falling
(FES: Falls Efficacy
Scale)

183
183
-
Falls: prevention of
fall accidents
(LASA ancillary study)

X-
Falls: 3y prospective
fall calendar
(LASA ancillary study)
X-
Falls: 1y prospective
fall calendar
(LASA ancillary study)

X-
DizzinessIM
187
187
187
187
187
187
187
187
187187
Adjustments and
walking aids**

187187187187187187187 --
Foot problems
185185185185-
FracturesBCDE2BFGH3BMBIJK
Fractures

- total waves b-f

- per wave

- tel. proxy*

- tel. respondent*


zo13







zo13

186

605

705


zo13

186

605

705


zo13

186

605

705


zo13

186





zo13

186

605

705





186

605

705






186

605

705






186







186







186

605

705






186

605

705






186

605

705

Vertebral
deformities

zo22zo22-
Quantitative
ultrasound of bone

o31o31-
Frailty
BCDE2BFGH3BMBIJK
Various definitions
(e.g., frailty
phenotype,
frailty index)

XX  X  X  X  X   X  XXXXX
LifestyleBCDE2BFGH3BMBIJK
Alcohol useIM
- scaled
153
353
153
353
153
353
153
353
153
353
153
353
153
353
153
353
153
353
153
353
153
353
153
353
153
353
Diet and food
consumption


Lifestyle study
(LASA ancillary study)


Nutrition and
food-related
behaviour
(LASA ancillary study)


with subtopics:
- Eating patterns
- Weight(loss) and appetite
- Mindful eating
- Meals and snack
- Interoceptive awareness
of hunger and satiety
- Alexithymia
- Binge eating
- Eating styles
- Problems food intake
- Use of amenities
- Food products for
older adults
- Dietary
recommendations
- Sustainable behaviour
- Change in sleep and 
change in appetite
118


-
118
184

118
184

-
-

-
-
-

-
-
-

X
-
-

-
118


-
-

-
-
-

-
118


118
-

-
118
-

-
MicMac study
(LASA ancillary study)

X
Oral health
X2126
126126
Physical activityIM
046
046 046 046 046 046 046 046 046 046 046 046 046
Daily Physical Activity**----------- 162-
Early life physical
activity

246
-
Perceived physical
activity (LIVAS)
– scaled
114

314
114

314
114

314
114

314
114

314
114

314












 –



Accelerometry
(LASA ancillary studies)
– subsample (St. 1)
– subsample (St. 2)
– subsample (St. 3)
– subsample (St. 4)



-
-
-
-


-
-
-
-


-
-
-
-


-
-
-
-


-
-
-
-


X2
-
-
-


-
X
-
-


-
-
X3
-


-
-
-
-


-
-
-
-


-
-
-
X
 

-
-
-
-


-
-
-
-
Sedentary behavior
– scaled
– scaled













101
301
501
101
301
501
101
301
501
101
301
501
101
301
501
101
301
501
101
301
501
SmokingIM
154154154154154154154154154154154154154
Medication/
supplements
BCDE2BFGH3BMBIJK
Medication and
food supplement
use4
– types of
medication

152


352
152


352
152


352
152


352
152


352
152


352
152


352
152


352
152


352
152


352
152


352
152


352
152


352
Food supplement
use4
- Vitamin D use
included



-


-


-


-


-


-


-


-


-


-
174

374
174

374
174

374
PainBCDE2BFGH3BMBIJK
Subjective painIM

- scaled

115

315

115

315

115

315

115

315

115

315

115

315

115

315

115

315

115

315

115

315

115

315

 115

315

115

315

Dealing with pain**
188
 --
Pain drawing
188
 --
Perception:
Vision
BCDE2BFGH3BMBIJK
Vision (self-report)IM
– total scores
– tel. proxy*
– tel. respondent*

031
231



031
231

604
704
031
231

604
704
031
231

604
704
031
231



031
231

604
704
031
231

604
704
031
231

604
704
031
231



031
-
-
-
031
231

604
704
031
231

604
704
031
231
604
704
Visual acuity test

- Vision-related
quality of life







191

192



191

192
191

192
191

192
191

-




 –



Vision: contrast
sensitivity

157157157157157157--
Perception:
Hearing
BCDE2BFGH3BMBIJK
Hearing (self-report)IM
– total scores
– tel. proxy*
– tel. respondent*

031
231

-
-
031
231

604
704
031
231

604
704
031
231

604
704
031
231


-
031
231

604
704
031
231

604
704
031
231

604
704
031
231


-
031



031
231

604
704
031
231

604
704
031
231
604
704
Hearing: Speech
in Noise Test (SNT)

Hearing: SNT
questions









193


194



193


194
193


194









193


194






Perception: smellBCDE2BFGH3BMBIJK
Olfactory function
S00
S01
S02
S00
S01
S02
Physical
functioning
BCDE2BFGH3BMBIJK
Funct. limitations (ADL)IM
– constructed
– tel. proxy*
– tel. respondent*


Use of assistive
devices or assistance


Limitations in joint mobility

Funct. limitations partner
(ADL)
030
230

-
-

030


-

-
030
230

603
703

030


183

030
230

603
703

030


183

-
030
230

603
703

030


183

139
030
230

-
-

030


-

-
030
230

603
703

030


-

139
030
230

603
703

030


-

139
030
230

603
703

030


-

139
030
230

-
-

030


-

139
030
230

-
-

030


-

-
030
230

603
703

030


-

139
030
230

603
703

030


-

139
030
230
603
703

030



-

139
Global Activity
Limitations**
- tel. respondent*
033

-
033

703
033

703
033

703
033

-
033

703
033

703
033

703
033

-


-
033

703
033

703
033

703
Physical
performance

034034034034034034034034034034034034034
Pulmonary function test
- Peak Flow

- Spirometry (post
bronchodilator)

158

-
158

-
158

-
158

-
-

-
-

-
158

-
158

-


168
-

-
-

-
-

-
-

-
Grip strength
161161161161161161161161161161161161
Quality of life
BCDE2BFGH3BMBIJK
EuroQol
– scaled




135
335

135
335
135
335
135
335
135
335

135
335


Qualeffo-41
– (non)response
– Qualeffo scores
– scaled


-
-

-
-

-
-
o80
o81
o82

-
-

-
-

-
-

-
-

-
-

-
-

-
-

-
-

-
-
SF-12 Health Survey
– scaled
– scaled (Am.)





133
333
533
133
333
533


133
333
533
133
333
533
133
333
533
133
333
533


133
333
533
133
333
533
133
333
533
WHO Quality of Life**
133
133133
Self-rated health
– GHPQ
– GHPQ: scaled
– tel. proxy*
– tel. respondent*

036
113
313


036
113
313

602
702
036
113
313

602
702
036
113
313

602
702
036
113
313


036
113
313

602
702
036
113
313

602
702
036
113
313

602
702
036
113
313


036
-

036
-
-
602
702
036
-
-
602
702
036
-
-
602
702
LASA-wave BCDE2BFGH3BMBIJK